C23H24N8O3
Neat
460.50
2272904-53-5; N-((1R, 2R)-2-Methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1, 2'-bipyridin]-3-yl)amino)pyrazolo[1, 5-a]pyrimidine-3-carboxamide; N-[(1R, 2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H), 2'-bipyridin]-3-yl)amino]-pyrazolo[1, 5-a]pyrimidine-3-carboxamide; N-((1R, 2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H), 2'-bipyridin)-3-yl)amino)-pyrazolo(1, 5-a)pyrimidine-3-carboxamide; N-((1R, 2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-(1, 2'-bipyridin)-3-yl)amino)pyrazolo(1, 5-a)pyrimidine-3-carboxamide; RefChem:822799; 957-394-0; 960-464-3; Zasocitinib; NDI-034858; TAK-279; C293MNS6TQ; TAK279; NDI034858; UNII-C293MNS6TQ; (8S)-N-[(1R, 2R)-2-methoxycyclobutyl]-7-(methylamino)-5-{[(1P, 2'P)-2-oxo-2H-[1, 2'-bipyridin]-3-yl]amino}pyrazolo[1, 5-a]pyrimidine-3-carboxamide; N-[(1R, 2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-ylpyridin-3-yl)amino]pyrazolo[1, 5-a]pyrimidine-3-carboxamide; Pyrazolo(1, 5-a)pyrimidine-3-carboxamide, N-((1R, 2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H), 2'-bipyridin)-3-yl)amino)-; Pyrazolo[1, 5-a]pyrimidine-3-carboxamide, N-[(1R, 2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H) and 2'-bipyridin]-3-yl)amino]-; zasocitinib [INN]
N-[(1R, 2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1 and 5-a]pyrimidine-3-carboxamide
InChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1